Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 675 entries
Sorted by: Best Match Show Resources per page
Antidepressant-related adverse effects impacting treatment compliance: Results of a patient survey.

Current therapeutic research, clinical and experimental

Ashton AK, Jamerson BD, L Weinstein W, Wagoner C.
PMID: 24672116
Curr Ther Res Clin Exp. 2005 Mar;66(2):96-106. doi: 10.1016/j.curtheres.2005.04.006.

BACKGROUND: Despite the high prevalence of depression in the United States, 10 few studies have identified which adverse effects (AEs) patients are willing or unwilling to tolerate when receiving antidepressants.OBJECTIVE: The aim of this study was to identify reasons...

Cite
Ashton AK, Jamerson BD, L Weinstein W, et al. Antidepressant-related adverse effects impacting treatment compliance: Results of a patient survey. Curr Ther Res Clin Exp. 2005;66(2):96-106doi: 10.1016/j.curtheres.2005.04.006.
Ashton, A. K., Jamerson, B. D., L Weinstein, W., & Wagoner, C. (2005). Antidepressant-related adverse effects impacting treatment compliance: Results of a patient survey. Current therapeutic research, clinical and experimental, 66(2), 96-106. https://doi.org/10.1016/j.curtheres.2005.04.006
Ashton, Adam Keller, et al. "Antidepressant-related adverse effects impacting treatment compliance: Results of a patient survey." Current therapeutic research, clinical and experimental vol. 66,2 (2005): 96-106. doi: https://doi.org/10.1016/j.curtheres.2005.04.006
Ashton AK, Jamerson BD, L Weinstein W, Wagoner C. Antidepressant-related adverse effects impacting treatment compliance: Results of a patient survey. Curr Ther Res Clin Exp. 2005 Mar;66(2):96-106. doi: 10.1016/j.curtheres.2005.04.006. PMID: 24672116; PMCID: PMC3964563.
Copy Download .nbib Format: NLM
Treatment-limiting toxicities associated withnucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational study.

Current therapeutic research, clinical and experimental

Palacios R, Santos J, Camino X, Arazo P, Torres Perea R, Echevarrfa S, Ribera E, Sánchez de la Rosa R, Moreno Guillen S.
PMID: 24672118
Curr Ther Res Clin Exp. 2005 Mar;66(2):117-29. doi: 10.1016/j.curtheres.2005.04.002.

BACKGROUND: The Recover Study is an ongoing, prospective study designed 10 to assess toxicity associated with the use of nucleoside analogue reverse transcriptase inhibitors (NRTIs) (stavudine, zidovudine, lamivudine, didanosine, abacavir) in HIV-1-infected patients receiving highly active antiretroviral therapy (HAART)...

Cite
Palacios R, Santos J, Camino X, et al. Treatment-limiting toxicities associated withnucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational study. Curr Ther Res Clin Exp. 2005;66(2):117-29doi: 10.1016/j.curtheres.2005.04.002.
Palacios, R., Santos, J., Camino, X., Arazo, P., Torres Perea, R., Echevarrfa, S., Ribera, E., Sánchez de la Rosa, R., Moreno Guillen, S. (2005). Treatment-limiting toxicities associated withnucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational study. Current therapeutic research, clinical and experimental, 66(2), 117-29. https://doi.org/10.1016/j.curtheres.2005.04.002
Palacios, Rosario, et al. "Treatment-limiting toxicities associated withnucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational study." Current therapeutic research, clinical and experimental vol. 66,2 (2005): 117-29. doi: https://doi.org/10.1016/j.curtheres.2005.04.002
Palacios R, Santos J, Camino X, Arazo P, Torres Perea R, Echevarrfa S, Ribera E, Sánchez de la Rosa R, Moreno Guillen S. Treatment-limiting toxicities associated withnucleoside analogue reverse transcriptase inhibitor therapy: A prospective, observational study. Curr Ther Res Clin Exp. 2005 Mar;66(2):117-29. doi: 10.1016/j.curtheres.2005.04.002. PMID: 24672118; PMCID: PMC3964549.
Copy Download .nbib Format: NLM
Effects of zafirlukast on the function of humanpolymorphonuclear neutrophil leukocytes in asthmatic patients: A prospective, controlled, in vitro study.

Current therapeutic research, clinical and experimental

Al-Zamil HA, Ai-Twaijiri AS, Al-Mobeireek AF, Mustafa AA.
PMID: 24672130
Curr Ther Res Clin Exp. 2005 Jul;66(4):279-93. doi: 10.1016/j.curtheres.2005.08.013.

BACKGROUND: Reactive oxygen species (ROSS) play an important role in the pathogenesis of asthma, and oxidative stress contributes to the initiation and worsening of inflammatory respiratory disorders (eg, asthma). Thus, antioxidant drugs may have a role in reducing or...

Cite
Al-Zamil HA, Ai-Twaijiri AS, Al-Mobeireek AF, et al. Effects of zafirlukast on the function of humanpolymorphonuclear neutrophil leukocytes in asthmatic patients: A prospective, controlled, in vitro study. Curr Ther Res Clin Exp. 2005;66(4):279-93doi: 10.1016/j.curtheres.2005.08.013.
Al-Zamil, H. A., Ai-Twaijiri, A. S., Al-Mobeireek, A. F., & Mustafa, A. A. (2005). Effects of zafirlukast on the function of humanpolymorphonuclear neutrophil leukocytes in asthmatic patients: A prospective, controlled, in vitro study. Current therapeutic research, clinical and experimental, 66(4), 279-93. https://doi.org/10.1016/j.curtheres.2005.08.013
Al-Zamil, Hana A, et al. "Effects of zafirlukast on the function of humanpolymorphonuclear neutrophil leukocytes in asthmatic patients: A prospective, controlled, in vitro study." Current therapeutic research, clinical and experimental vol. 66,4 (2005): 279-93. doi: https://doi.org/10.1016/j.curtheres.2005.08.013
Al-Zamil HA, Ai-Twaijiri AS, Al-Mobeireek AF, Mustafa AA. Effects of zafirlukast on the function of humanpolymorphonuclear neutrophil leukocytes in asthmatic patients: A prospective, controlled, in vitro study. Curr Ther Res Clin Exp. 2005 Jul;66(4):279-93. doi: 10.1016/j.curtheres.2005.08.013. PMID: 24672130; PMCID: PMC3964553.
Copy Download .nbib Format: NLM
Comparison of on-site and photographic evaluations of the suppressive effects of cetirizine, loratadine, and fexofenadine on skin response to histamine lontophoresis: A double-blind, crossover study in healthy volunteers.

Current therapeutic research, clinical and experimental

Tsuda H, Takiwaki H.
PMID: 24672131
Curr Ther Res Clin Exp. 2005 Jul;66(4):307-22. doi: 10.1016/j.curtheres.2005.08.011.

BACKGROUND: The standard method used to determine the potency of antihistaminesis to assess the degree of suppression of skin response to histamine challenge.OBJECTIVES: The aims of this study were to compare the efficacy of 3 antihistaminesusing a histamine challenge...

Cite
Tsuda H, Takiwaki H. Comparison of on-site and photographic evaluations of the suppressive effects of cetirizine, loratadine, and fexofenadine on skin response to histamine lontophoresis: A double-blind, crossover study in healthy volunteers. Curr Ther Res Clin Exp. 2005;66(4):307-22doi: 10.1016/j.curtheres.2005.08.011.
Tsuda, H., & Takiwaki, H. (2005). Comparison of on-site and photographic evaluations of the suppressive effects of cetirizine, loratadine, and fexofenadine on skin response to histamine lontophoresis: A double-blind, crossover study in healthy volunteers. Current therapeutic research, clinical and experimental, 66(4), 307-22. https://doi.org/10.1016/j.curtheres.2005.08.011
Tsuda, Hidetaka, and Takiwaki, Hirotsugu. "Comparison of on-site and photographic evaluations of the suppressive effects of cetirizine, loratadine, and fexofenadine on skin response to histamine lontophoresis: A double-blind, crossover study in healthy volunteers." Current therapeutic research, clinical and experimental vol. 66,4 (2005): 307-22. doi: https://doi.org/10.1016/j.curtheres.2005.08.011
Tsuda H, Takiwaki H. Comparison of on-site and photographic evaluations of the suppressive effects of cetirizine, loratadine, and fexofenadine on skin response to histamine lontophoresis: A double-blind, crossover study in healthy volunteers. Curr Ther Res Clin Exp. 2005 Jul;66(4):307-22. doi: 10.1016/j.curtheres.2005.08.011. PMID: 24672131; PMCID: PMC3964551.
Copy Download .nbib Format: NLM
Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India.

Current therapeutic research, clinical and experimental

Sudarshan MK, Madhusudana SN, Mahendra BJ, Ashwath Narayana DH, Ananda Giri MS, Popova O, Vakil HB.
PMID: 24672132
Curr Ther Res Clin Exp. 2005 Jul;66(4):323-34. doi: 10.1016/j.curtheres.2005.08.009.

BACKGROUND: Human rabies is an ongoing significant public health problem inmany developing countries, with India reporting the highest incidence of rabies-related deaths (∼20,000 per year). Many people living in India cannot afford the standard IM postexposure prophylaxis (PEP) with...

Cite
Sudarshan MK, Madhusudana SN, Mahendra BJ, et al. Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India. Curr Ther Res Clin Exp. 2005;66(4):323-34doi: 10.1016/j.curtheres.2005.08.009.
Sudarshan, M. K., Madhusudana, S. N., Mahendra, B. J., Ashwath Narayana, D. H., Ananda Giri, M. S., Popova, O., & Vakil, H. B. (2005). Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India. Current therapeutic research, clinical and experimental, 66(4), 323-34. https://doi.org/10.1016/j.curtheres.2005.08.009
Sudarshan, M K, et al. "Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India." Current therapeutic research, clinical and experimental vol. 66,4 (2005): 323-34. doi: https://doi.org/10.1016/j.curtheres.2005.08.009
Sudarshan MK, Madhusudana SN, Mahendra BJ, Ashwath Narayana DH, Ananda Giri MS, Popova O, Vakil HB. Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India. Curr Ther Res Clin Exp. 2005 Jul;66(4):323-34. doi: 10.1016/j.curtheres.2005.08.009. PMID: 24672132; PMCID: PMC3964532.
Copy Download .nbib Format: NLM
Comparison of the effects of ketamine or lidocaine on fentanyl-induced cough in patients undergoing surgery: A prospective, double-blind, randomized, placebo-controlled study.

Current therapeutic research, clinical and experimental

Guler G, Aksu R, Bicer C, Tosun Z, Boyaci A.
PMID: 24688150
Curr Ther Res Clin Exp. 2010 Oct;71(5):289-97. doi: 10.1016/j.curtheres.2010.10.004.

BACKGROUND: Fentanyl-induced cough is common but has not been viewed as a serious anesthetic problem. However, the cough may be explosive at times, may require immediate intervention, and may be associated with undesirable increases in intracranial, intraocular, and intra-abdominal...

Cite
Guler G, Aksu R, Bicer C, et al. Comparison of the effects of ketamine or lidocaine on fentanyl-induced cough in patients undergoing surgery: A prospective, double-blind, randomized, placebo-controlled study. Curr Ther Res Clin Exp. 2010;71(5):289-97doi: 10.1016/j.curtheres.2010.10.004.
Guler, G., Aksu, R., Bicer, C., Tosun, Z., & Boyaci, A. (2010). Comparison of the effects of ketamine or lidocaine on fentanyl-induced cough in patients undergoing surgery: A prospective, double-blind, randomized, placebo-controlled study. Current therapeutic research, clinical and experimental, 71(5), 289-97. https://doi.org/10.1016/j.curtheres.2010.10.004
Guler, Gülen, et al. "Comparison of the effects of ketamine or lidocaine on fentanyl-induced cough in patients undergoing surgery: A prospective, double-blind, randomized, placebo-controlled study." Current therapeutic research, clinical and experimental vol. 71,5 (2010): 289-97. doi: https://doi.org/10.1016/j.curtheres.2010.10.004
Guler G, Aksu R, Bicer C, Tosun Z, Boyaci A. Comparison of the effects of ketamine or lidocaine on fentanyl-induced cough in patients undergoing surgery: A prospective, double-blind, randomized, placebo-controlled study. Curr Ther Res Clin Exp. 2010 Oct;71(5):289-97. doi: 10.1016/j.curtheres.2010.10.004. PMID: 24688150; PMCID: PMC3969624.
Copy Download .nbib Format: NLM
Effects of lorglumide on growth and invasion of human pancreatic cancer cell line Mia PaCa-2 in vitro through the cholecystokinin-cholecystokinin-1 receptor pathway.

Current therapeutic research, clinical and experimental

Zhou J, Zhang ZX, Li DC.
PMID: 24688146
Curr Ther Res Clin Exp. 2010 Aug;71(4):239-51. doi: 10.1016/j.curtheres.2010.08.005.

BACKGROUND: Cholecystokinin (CCK) has been found to be a growth stimulant through its special receptor pathway, especially for gastrointestinal malignancies. Although the CCK-1 receptor has been shown to be highly expressed in resected human pancreatic cancer samples, its role...

Cite
Zhou J, Zhang ZX, Li DC. Effects of lorglumide on growth and invasion of human pancreatic cancer cell line Mia PaCa-2 in vitro through the cholecystokinin-cholecystokinin-1 receptor pathway. Curr Ther Res Clin Exp. 2010;71(4):239-51doi: 10.1016/j.curtheres.2010.08.005.
Zhou, J., Zhang, Z. X., & Li, D. C. (2010). Effects of lorglumide on growth and invasion of human pancreatic cancer cell line Mia PaCa-2 in vitro through the cholecystokinin-cholecystokinin-1 receptor pathway. Current therapeutic research, clinical and experimental, 71(4), 239-51. https://doi.org/10.1016/j.curtheres.2010.08.005
Zhou, Jin, et al. "Effects of lorglumide on growth and invasion of human pancreatic cancer cell line Mia PaCa-2 in vitro through the cholecystokinin-cholecystokinin-1 receptor pathway." Current therapeutic research, clinical and experimental vol. 71,4 (2010): 239-51. doi: https://doi.org/10.1016/j.curtheres.2010.08.005
Zhou J, Zhang ZX, Li DC. Effects of lorglumide on growth and invasion of human pancreatic cancer cell line Mia PaCa-2 in vitro through the cholecystokinin-cholecystokinin-1 receptor pathway. Curr Ther Res Clin Exp. 2010 Aug;71(4):239-51. doi: 10.1016/j.curtheres.2010.08.005. PMID: 24688146; PMCID: PMC3969616.
Copy Download .nbib Format: NLM
Pharmacokinetics of depside salts from Salvia miltiorrhiza in healthy Chinese volunteers: A randomized, open-label, single-dose study.

Current therapeutic research, clinical and experimental

Jia JY, Lu YL, Li XC, Liu GY, Li SJ, Liu Y, Liu YM, Yu C, Wang YP.
PMID: 24688148
Curr Ther Res Clin Exp. 2010 Aug;71(4):260-71. doi: 10.1016/j.curtheres.2010.08.004.

BACKGROUND: Depside salts from Salvia miltiorrhiza, with active components of lithospermic acid B (LSB), rosmarinic acid (RA), and lithospermic acid (LA), are a multicomponent drug marketed in China for the treatment of coronary heart disease.OBJECTIVES: The aims of this...

Cite
Jia JY, Lu YL, Li XC, et al. Pharmacokinetics of depside salts from Salvia miltiorrhiza in healthy Chinese volunteers: A randomized, open-label, single-dose study. Curr Ther Res Clin Exp. 2010;71(4):260-71doi: 10.1016/j.curtheres.2010.08.004.
Jia, J. Y., Lu, Y. L., Li, X. C., Liu, G. Y., Li, S. J., Liu, Y., Liu, Y. M., Yu, C., & Wang, Y. P. (2010). Pharmacokinetics of depside salts from Salvia miltiorrhiza in healthy Chinese volunteers: A randomized, open-label, single-dose study. Current therapeutic research, clinical and experimental, 71(4), 260-71. https://doi.org/10.1016/j.curtheres.2010.08.004
Jia, Jing-Ying, et al. "Pharmacokinetics of depside salts from Salvia miltiorrhiza in healthy Chinese volunteers: A randomized, open-label, single-dose study." Current therapeutic research, clinical and experimental vol. 71,4 (2010): 260-71. doi: https://doi.org/10.1016/j.curtheres.2010.08.004
Jia JY, Lu YL, Li XC, Liu GY, Li SJ, Liu Y, Liu YM, Yu C, Wang YP. Pharmacokinetics of depside salts from Salvia miltiorrhiza in healthy Chinese volunteers: A randomized, open-label, single-dose study. Curr Ther Res Clin Exp. 2010 Aug;71(4):260-71. doi: 10.1016/j.curtheres.2010.08.004. PMID: 24688148; PMCID: PMC3969617.
Copy Download .nbib Format: NLM
Annual author/subject indexes.

Current therapeutic research, clinical and experimental

[No authors listed]
PMID: 24688161
Curr Ther Res Clin Exp. 2010 Dec;71(6):418-23. doi: 10.1016/S0011-393X(10)80008-6.

No abstract available.

Cite
Annual author/subject indexes. Curr Ther Res Clin Exp. 2010;71(6):418-23doi: 10.1016/S0011-393X(10)80008-6.
(2010). Annual author/subject indexes. Current therapeutic research, clinical and experimental, 71(6), 418-23. https://doi.org/10.1016/S0011-393X(10)80008-6
"Annual author/subject indexes." Current therapeutic research, clinical and experimental vol. 71,6 (2010): 418-23. doi: https://doi.org/10.1016/S0011-393X(10)80008-6
Annual author/subject indexes. Curr Ther Res Clin Exp. 2010 Dec;71(6):418-23. doi: 10.1016/S0011-393X(10)80008-6. PMID: 24688161; PMCID: PMC3969623.
Copy Download .nbib Format: NLM
A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study.

Current therapeutic research, clinical and experimental

Hanžel J, Piletič Ž, Turk M, Eržen B, Šabovič M.
PMID: 26199676
Curr Ther Res Clin Exp. 2015 Jun 06;77:63-5. doi: 10.1016/j.curtheres.2015.06.001. eCollection 2015 Dec.

BACKGROUND: Despite optimum treatment, patients who experience myocardial infarction are still at high risk for future events.OBJECTIVE: We evaluated the effect of 30 days of treatment with combination of low, subtherapeutic doses of fluvastatin and valsartan on arterial stiffness...

Cite
Hanžel J, Piletič Ž, Turk M, et al. A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study. Curr Ther Res Clin Exp. 2015;77:63-5doi: 10.1016/j.curtheres.2015.06.001.
Hanžel, J., Piletič, �. �., Turk, M., Eržen, B., & Šabovič, M. (2015). A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study. Current therapeutic research, clinical and experimental, 7763-5. https://doi.org/10.1016/j.curtheres.2015.06.001
Hanžel, Jurij, et al. "A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study." Current therapeutic research, clinical and experimental vol. 77 (2015): 63-5. doi: https://doi.org/10.1016/j.curtheres.2015.06.001
Hanžel J, Piletič Ž, Turk M, Eržen B, Šabovič M. A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study. Curr Ther Res Clin Exp. 2015 Jun 06;77:63-5. doi: 10.1016/j.curtheres.2015.06.001. eCollection 2015 Dec. PMID: 26199676; PMCID: PMC4506977.
Copy Download .nbib Format: NLM
Liposome Bupivacaine for Postsurgical Analgesia in Adult Patients Undergoing Laparoscopic Colectomy: Results from Prospective Phase IV Sequential Cohort Studies Assessing Health Economic Outcomes.

Current therapeutic research, clinical and experimental

Candiotti KA, Sands LR, Lee E, Bergese SD, Harzman AE, Marcet J, Kumar AS, Haas E.
PMID: 25031661
Curr Ther Res Clin Exp. 2013 Dec 27;76:1-6. doi: 10.1016/j.curtheres.2013.12.001. eCollection 2014 Dec.

BACKGROUND: Opioid-based postsurgical analgesia exposes patients undergoing laparoscopic colectomy to elevated risk for gastrointestinal motility problems and other opioid-related adverse events (ORAEs). The purpose of our research was to investigate postsurgical outcomes, including opioid consumption, hospital length of stay,...

Cite
Candiotti KA, Sands LR, Lee E, et al. Liposome Bupivacaine for Postsurgical Analgesia in Adult Patients Undergoing Laparoscopic Colectomy: Results from Prospective Phase IV Sequential Cohort Studies Assessing Health Economic Outcomes. Curr Ther Res Clin Exp. 2013;76:1-6doi: 10.1016/j.curtheres.2013.12.001.
Candiotti, K. A., Sands, L. R., Lee, E., Bergese, S. D., Harzman, A. E., Marcet, J., Kumar, A. S., & Haas, E. (2014). Liposome Bupivacaine for Postsurgical Analgesia in Adult Patients Undergoing Laparoscopic Colectomy: Results from Prospective Phase IV Sequential Cohort Studies Assessing Health Economic Outcomes. Current therapeutic research, clinical and experimental, 761-6. https://doi.org/10.1016/j.curtheres.2013.12.001
Candiotti, Keith A, et al. "Liposome Bupivacaine for Postsurgical Analgesia in Adult Patients Undergoing Laparoscopic Colectomy: Results from Prospective Phase IV Sequential Cohort Studies Assessing Health Economic Outcomes." Current therapeutic research, clinical and experimental vol. 76 (2014): 1-6. doi: https://doi.org/10.1016/j.curtheres.2013.12.001
Candiotti KA, Sands LR, Lee E, Bergese SD, Harzman AE, Marcet J, Kumar AS, Haas E. Liposome Bupivacaine for Postsurgical Analgesia in Adult Patients Undergoing Laparoscopic Colectomy: Results from Prospective Phase IV Sequential Cohort Studies Assessing Health Economic Outcomes. Curr Ther Res Clin Exp. 2013 Dec 27;76:1-6. doi: 10.1016/j.curtheres.2013.12.001. eCollection 2014 Dec. PMID: 25031661; PMCID: PMC3994919.
Copy Download .nbib Format: NLM
Effect of an Echinacea-Based Hot Drink Versus Oseltamivir in Influenza Treatment: A Randomized, Double-Blind, Double-Dummy, Multicenter, Noninferiority Clinical Trial.

Current therapeutic research, clinical and experimental

Rauš K, Pleschka S, Klein P, Schoop R, Fisher P.
PMID: 26265958
Curr Ther Res Clin Exp. 2015 Apr 20;77:66-72. doi: 10.1016/j.curtheres.2015.04.001. eCollection 2015 Dec.

BACKGROUND: Echinacea has antiviral activity against influenza viruses in vitro and has traditionally been used for treatment of colds and flu.OBJECTIVES: This randomized, double-blind, double-dummy, multicenter, controlled clinical trial compared a new echinacea formulation with the neuraminidase inhibitor oseltamivir,...

Cite
Rauš K, Pleschka S, Klein P, et al. Effect of an Echinacea-Based Hot Drink Versus Oseltamivir in Influenza Treatment: A Randomized, Double-Blind, Double-Dummy, Multicenter, Noninferiority Clinical Trial. Curr Ther Res Clin Exp. 2015;77:66-72doi: 10.1016/j.curtheres.2015.04.001.
Rauš, K., Pleschka, S., Klein, P., Schoop, R., & Fisher, P. (2015). Effect of an Echinacea-Based Hot Drink Versus Oseltamivir in Influenza Treatment: A Randomized, Double-Blind, Double-Dummy, Multicenter, Noninferiority Clinical Trial. Current therapeutic research, clinical and experimental, 7766-72. https://doi.org/10.1016/j.curtheres.2015.04.001
Rauš, Karel, et al. "Effect of an Echinacea-Based Hot Drink Versus Oseltamivir in Influenza Treatment: A Randomized, Double-Blind, Double-Dummy, Multicenter, Noninferiority Clinical Trial." Current therapeutic research, clinical and experimental vol. 77 (2015): 66-72. doi: https://doi.org/10.1016/j.curtheres.2015.04.001
Rauš K, Pleschka S, Klein P, Schoop R, Fisher P. Effect of an Echinacea-Based Hot Drink Versus Oseltamivir in Influenza Treatment: A Randomized, Double-Blind, Double-Dummy, Multicenter, Noninferiority Clinical Trial. Curr Ther Res Clin Exp. 2015 Apr 20;77:66-72. doi: 10.1016/j.curtheres.2015.04.001. eCollection 2015 Dec. PMID: 26265958; PMCID: PMC4528044.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 675 entries